CapitalXP Review: Regulatory Warning Signs and Cloned-Firm Red Flags
We brought CapitalXP onto a single screen — licensing, ownership, and the withdrawal trail — and read what the evidence showed. The picture that emerged is one of elevated risk: CapitalXP has drawn cautions from…